Internal Control Improvements - The company has identified multiple deficiencies in its internal controls, including the lack of a related party transaction identification record and guidelines[3] - The company has committed to improving its internal control systems, including the establishment of a review committee composed of three independent non-executive directors[5] - The company has engaged an external consultant to conduct an internal control review and provide recommendations for strengthening related party transaction monitoring[10] - The company has taken remedial actions following the identification of non-compliance records in 2019 and 2020, enhancing its internal control systems[6] - The board has reviewed the internal control system and strengthened procedures to improve risk management and internal controls[14] - After implementing remedial measures, the company maintains appropriate and effective risk management and internal control systems[14] Related Party Transactions Management - The company has implemented measures to ensure compliance with listing rules regarding related party transactions, including regular updates of the related party list[11] - The company has revised its related party transaction management policy to ensure adherence to listing rules, including annual confirmations of related party information[12] - The company has established a financial department responsible for reviewing all transactions to determine if they require disclosure under listing rules[13] - The company has arranged training courses for directors and relevant staff to improve understanding of related party transactions and disclosure requirements[10] - The company has committed to more frequent reviews of related party transaction ledgers and monthly confirmations from related parties[12] - The company has implemented a system to ensure that all transactions are reviewed by the financial department and reported to the board if they require disclosure[13] Financial Oversight - The company has prepared an annual investment budget and will regularly review it[14] - The finance department and financial supervisor will continue to monitor compliance with listing rules and regulations[14]
福森药业(01652) - 2024 - 年度业绩